Latest Myelin Stories
Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain.
By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease.
NEW YORK and NORTH BRUNSWICK, N.J., Nov.
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine.
Scientists are closer to solving one of the many mysteries of multiple sclerosis and other demyelinating diseases, thanks to a recent study conducted at the Salk Institute for Biological Studies.
Scientists have uncovered a source of damage associated with multiple sclerosis (MS) that may lead them to an effective therapy for what is now an incurable condition.
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder.
Researchers in Germany have gained new insight into how the immune system causes damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder.
NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010.
Albuterol Sulfate, a compound commonly used to treat asthma and other respiratory diseases, may decrease levels of a biological compound that promotes generation of a helper cell in patients with multiple sclerosis.